Caveolae, the cave-like structures abundant in endothelial cells (ECs), are important in regulating key functions such as caveolae-mediated endocytosis and generation of nitric oxide. Here we show that deletion of the receptor tyrosine kinase EphB1 (EphB1 −/− ) in mice markedly reduced the caveolae number in ECs of heart and lung vessels and prevented caveolae-mediated endocytosis. EphB1 expressed in adult ECs was shown to bind the caveolin-1 (Cav-1) scaffold domain (CSD) via the CSD binding motif (CSDBM) on EphB1. We demonstrated that activation of EphB1 by the native ligand Ephrin B1 uncoupled EphB1 from Cav-1, and licensed Src-dependent Y-14 Cav-1 phosphorylation. Deletion of CSDBM on EphB1 prevented EphB1/Cav-1 interaction and the activation of Src and Src mediated Y-14 Cav-1 phosphorylation. These studies identify the central role of endothelium expressed EphB1 in regulating caveolae biogenesis and caveolae-mediated endocytosis.
Introduction
The erythropoietin-producing hepatocellular carcinoma (Eph) receptor tyrosine kinases and their ligands (Ephrins) are expressed multiple cell types (1, 2) . Ephrins have important roles in regulating neuronal and vascular development, axon guidance, and maintenance of cell-specific identities (3) (4) (5) (6) . While the functions of Ephrins are known in the embryo, their molecular understanding in adult cells is less clear (1) (2) (3) (4) (5) (6) . Here based on evidence of the key role of Ephrins in vascular development, postnatal angiogenesis, and vascular integrity (5) (6) (7) (8) (9) , we investigated whether they can be redeployed in adult endothelial cells (EC) to regulate vascular function.
Caveolae are plasma membrane invaginations in ECs (10) (11) (12) in which caveolin-1 (Cav-1) is a primary structural and signaling protein inserted in the caveolar membrane (11) (12) (13) (14) . Both Cav-1 and the isoform Cav-2 are expressed in ECs (12, 15 ) and low-affinity electrostatically controlled protein-protein interactions between the two enables the formation of caveolae (15) (16) (17) (18) . Caveolae on the luminal side of ECs have several functions (16) among them loading of cargo and caveolae-mediated endocytosis (17) . Deletion of Cav-1 (Cav-1 -/-) in mice showed flattening of caveolae indicating the importance of Cav-1 for the formation of caveolae in ECs (19, 20) . Further, these mice failed internalize tracer proteins in contrast to controls (19, 20) . We showed that Src kinase-mediated phosphorylation of Cav-1 on Y-14 was required for fission of caveolae from the plasma membrane and caveolae-mediated endocytosis (21) (22) (23) . Cav-1 scaffold domain (CSD) binds other proteins via a peptide sequence in CSD-interacting proteins, the CSD binding motif (CSDBM) (Fig. 1A) . Several of these key binding proteins have been identified including Src tyrosine kinases, eNOS (endothelial nitric oxide synthase), and trimeric G protein subunits, Ras, and PPARg (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) . Interestingly, in a study using CHO cells, it was shown that EphB1 can also bind CSD via its CSDBM ( 808 WSYGIVMW 815 ) and target the plasma membrane (34) ; however, while this study raised the potential for this interaction it did not address the mechanism of this interaction and in functional significance in the endothelium.
In the present study, using mouse models and endothelial cells, we showed a crucial function of EphB1 in regulating the genesis of caveolae in ECs. Deletion of EphB1 in mice severely depleted caveolae numbers.
Activation of EphB1 with the ligand Ephrin B1 disassociated EphB1 from Cav-1 to induce EphB1 auto-phosphorylation on Y-600 via EphB1's kinase domain and thereby recruited Src. We demonstrated that Src activation secondary to its recruitment induced Cav-1 phosphorylation on Y-14 and was required for the initiation of caveolae-mediated endocytosis. Thus, our results demonstrate an intersection between EphB1 and Cav-1 through a binding interaction that regulates the biogenesis and function of caveolae in ECs important in vascular homeostasis.
Results

EphB1 binds the Cav-1 scaffold domain in endothelial cells. Studies were made in human lung microvascular
ECs (HLMVECs) prominently expressing both EphB1 ( Fig. 1A) and Cav-1 (Fig. 1B) . Using 3D-SIM superresolution microscopy, we observed an interaction between EphB1 and Cav-1 as measured by Manders overlap coefficient (MOC) (35) (Fig. 1C) . In unstimulated cells, both EphB1 and Cav-1 were clustered in multilobed caveolar rosettes (Fig. 1C) . In other studies, co-expression of EphB1 and Cav-1 in COS-1 cells also showed a strong interaction ( Fig. 1D-E; Supplemental Figure 1A and B ). Using the mutant EphB1 D808-815 in which CSDBM is deleted, we observed that it did not bind WT-Cav-1 ( Fig. 1F; Supplemental Figure 1A and B ).
To determine whether activation of EphB1 influences EphB1/Cav-1 interaction, we added Ephrin B1-Fc to COS-1 cells co-expressing EphB1 and Cav-1. Soluble Ephrin extracellular domain fused to Fc domain (Ephrin-Fc), a standard Eph receptor agonist (1, 2) , was added. Ephrin B1-Fc significantly reduced EphB1/Cav-1 interaction ( Fig. 1E; Supplemental Figure 1A and B) . To further study this interaction, we also co-expressed WT-EphB1-YFP with either WT-Cav-1-CFP or mutant EphB1 D808-815 -YFP with WT-Cav-1-CFP in COS-1 cells, and measured live cell FRET efficiency (23) . Cells co-expressing WT-EphB1-YFP and WT-Cav-1-CFP activated by Ephrin B1-Fc showed markedly reduced FRET intensity ( Fig. 1G) whereas cells co-expressing EphB1 D808-815 -YPF and WT-Cav-1-CFP showed no significant response ( Fig. 1G) . We also determined EphB1/Cav-1 interaction in murine lung ECs (C57BL/6 mice) by immunostaining using antibodies to EphB1 and Cav-1, and observed marked co-localization in caveolae which was markedly reduced within minutes of adding Ephrin B1 with the effect reversed over time ( Fig. 1 H; Supplemental Figure 1C tyrosine residues (Y 594 and Y 600 ) in its juxta-membrane region (1, 2, 7, 36) . Ephrin B1 activation of EphB1 is known to induce auto-phosphorylation of EphB1 on Y 600 , which thereby binds Src homology-2 (SH2) domain of Src family kinases (SFKs) to activate SFKs (36) . To address whether EphB1 contributes Src-dependent phosphorylation of Cav-1 on Y-14, we measured Ephrin B1-induced EphB1 autophosphorylation, Src activation, and Y-14 phosphorylation of Cav-1 in HLMVECs. We observed that Ephrin B1 induced EphB1 autophosphorylation on Y 600 , phosphorylation of Src on Y-416 as well as Cav-1 on Y-14 ( Fig. 2, B-D) . Since other EphB receptors may also be activated by Ephrin B1, we addressed whether the effects of the ligand in ECs were specific to EphB1. Thus, we used an EphB1 selective antagonistic peptide (EphB1-A-pep) ( Fig. 2A) (37, 38) , which prevents binding of Ephrin B1 to EphB1 ligand binding domain and blocks EphB1 signaling (37, 38) .
HLMVECs treated with EphB1-A-pep prevented Ephrin B1-induced EphB1 auto-phosphorylation ( Fig. 2B) , Src activation (p-Y416) (Fig. 2C) , and pY-14 Cav-1 phosphorylation as compared to a control peptide ( Fig. 2D) .
We next determined whether the cell-permeable synthetic CSD (antennapedia (AP)-CSD) peptide can also prevent EphB1/Cav-1 interaction and downstream Src activation. Ephrin B1-Fc stimulation caused autotyrosine phosphorylation of EphB1, Src binding to EphB1, and phosphorylation of Src at Y-416 and of Cav-1 at Y-14 in control AP peptide-treated HLMVECs whereas these responses in AP-CSD peptide-loaded cells were blocked ( Fig. 2E) .
To define further EphB1-mediated Src activation and Cav-1 phosphorylation, we co-expressed WT-EphB1-YFP, mutant EphB1 D808-815 -YFP, or mutant EphB1 Y600F -YFP with WT-Cav-1-CFP in COS-1 cells. In WT-EphB1-and WT-Cav-1 co-expressing cells, we observed auto-phosphorylation of EphB1 and phosphorylation of both Src on Y-416 and Cav-1 on Y-14, which were both increased by the Ephrin B1-Fc ligand ( Fig. 2F) . In EphB1 D808-815 and WT-Cav-1 co-expressing cells, we observed inhibition of basal as well as Ephrin B1-induced auto-phosphorylation of EphB1 as well as phosphorylation of Src and Cav-1 ( Fig. 2F) . Similar results were seen in mutant EphB1 Y600F and WT-Cav-1 co-expressing cells (Fig. 2F) . Thus, the interaction of CSD and CSDBM is required for Ephrin B1-induced auto-phosphorylation of EphB1 on Y-600, EphB1-mediated Src activation, and Cav-1 phosphorylation on Y-14.
EphB1 regulates the biogenesis of caveolae. We next studied mice in which EphB1 was deleted (EphB1 -/-) and in mice expressing EphB1-tc (EphB1-bgal fusion receptor lacking the tyrosine kinase and C-terminal domains).
Western blot analysis of lung tissue and isolated lung ECs showed the absence of EphB1 expression in EphB1 -/mice (Supplemental Figure 2, A and B ) and expression of EphB1-bgal fusion receptor in EphB1-tc mice (Supplemental Figure 2, A and B ). Immunostaining of lung sections from EphB1-tc mice with antibodies specific to b-gal and vWF (an EC marker) showed b-gal expression in blood vessels (Supplemental Figure 2C) .
As EphB1 interacts with Cav-1 as shown above, using ECs obtained from EphB1 −/− mice we determined whether EphB1 is involved in regulating Cav-1 expression, and found that Cav-1 protein expression was markedly reduced in EphB1 −/− mice as compared to WT (Fig. 3A) ; however, decreased Cav-1 protein expression was not associated with reduced Cav-1 mRNA in EphB1 −/− mice (Fig. 3B ). Since Cav-1 expression may be downregulated by ubiquitination via the proteasomal pathway (39, 40) , we observed increased ubiquitination of Cav-1 in lung ECs of EphB1 −/− mice compared to WT ( Fig. 3C) . We also determined the expression of caveolar coat proteins cavin-1 and -2 important for caveolae biogenesis (41, 42) . Cavin-1 expression was similar in both WT and EphB1 −/− mice and Cavin-2 expression was not reduced in EphB1 -/-ECs ( Fig. 3D) , ruling out reduced Cavin-1, -2 expression as the basis of defective caveolae biogenesis in EphB1 −/− mice.
By ultrastructural analysis of caveolae, we confirmed defective caveolar morphogenesis in lung and heart microvascular endothelia of EphB1 −/− mice (Fig. 4, A and C) . The number of caveolae was significantly reduced in ECs of lungs ( Fig. 4A, right panel Fig. 4C , right panel). However, there was no difference in the caveolar shape ( Fig. 4A and C) or inter-endothelial junctions (IEJs) (Fig. 4B ).
Studies were also made using lung ECs from WT and EphB1 −/− mice in which we determined morphology and function of caveolae (defined as Cav-1+ve structures) using 3D-SIM super-resolution microscopy. Cav-1+ve caveolae number was markedly reduced in ECs of EphB1 −/− mice and caveolar rosette-like structures in ECs formed by fusion of multiple caveolae were not seen in ECs from EphB1 −/− mice as compared to WT ( Fig. 4D) .
EphB1 is required for caveolae endocytosis. To address the requirement for EphB1 in signaling caveolae mediated endocytosis, we used ECs EphB1 -/as well as from Cav-1 -/-, and determined caveolae-mediated endocytosis in response to Ephrin B1. Ephrin B1 induced time-dependent increases in phosphorylation of Src on Y-416 and Y-14 Cav-1 in WT ECs whereas these responses were blocked in ECs from Cav-1 -/mice ( Fig. 5A,   B ). In ECs from EphB1 −/− mice, we observed that Ephrin B1-induced phosphorylation on Src Y-416 and Cav-1 Y-14 were also blocked ( Fig. 5C and D) . Using ECs from EphB1 -/and Cav-1 -/mice, we next addressed whether EphB1/Cav-1 interaction was required for signaling caveolae-mediated endocytosis. Here we determined the endocytic function of caveolae by quantifying the uptake of tracer albumin Alexa Fluor-594 labeled bovine serum albumin tracer (Alexa-594 BSA) (17, 23, 43) using ECs from EphB1 -/and Cav-1 -/mice. Studies were made in ECs incubated with serum free medium for 2h followed by addition of Ephrin B1-Fc ligand (1 µg/ml) in medium containing 100 µg/ml albumin tracer plus 2 mg/ml unlabeled albumin. Analysis of single cell 3D images showed a time-dependent albumin internalization in ECs from WT mice as early as 5 min after tracer addition.
We observed 16 ± 3 particles/cell with maximum uptake of 850 ± 14 particles/cell attained seen at 60 min ( Fig.   6A and Table 1 ). We also observed that internalized albumin particles trafficked into the cell, ~3 µm from the apical side ( Fig. 6A) . Numerous Cav-1+ve caveolae were seen in ECs of WT mice ( Fig. 6A) whereas ECs from EphB1 -/mice showed 4-fold reduction in albumin tracer internalization (in WT-ECs 850 ± 14 particles/cell at 60 min vs. in EphB1 -/--ECs 216 ± 16 particles/cell) ( Fig. 6A, B ; Table 1 ). We similarly measured albumin internalization in ECs of Cav-1 -/mice as a comparison with EphB1 -/--ECs, and also observed inhibition of timedependent internalization of albumin particles in Cav-1 -/--ECs (Fig. 6C, D and Table 1 ).
We also addressed the in vivo relevance of EphB1/Cav-1 interaction in mediating endocytosis in endothelia using tracer 125 I-albumin (44) . EphB1 −/− mice showed a marked reduction in endothelial 125 I-albumin uptake as compared to WT (Fig. 6E) . Treatment with an anti-EphB1 pAb receptor blocking antibody significantly reduced 125 I-albumin uptake (Fig. 6F) , indicating that EphB1 is required for caveolar endocytosis in vivo.
Discussion
In the present study, we have uncovered a functionally important association of the receptor tyrosine kinase EphB1 with Cav-1 in endothelial cells in coordinately regulating the activation of Src and Src mediated phosphorylation of Cav-1 on Y14 in response to activation of EphB1. We showed that CSDBM of EphB1 is constitutively bound to the scaffold domain of Cav-1 (CSD) masking the EphB1 kinase domain, and thus holding Src activity in abeyance. However, the activation of EphB1 by its native ligand Ephrin B1 uncoupled EphB1 from Cav-1, exposing the EphB1 kinase domain to activate Src and Src-dependent phosphorylation of Y-14 Cav-1, a phospho-active site on Cav-1 (21-23) that signaled endocytosis of caveolae.
Multiple signaling proteins have been shown to bind CSD like EphB1 described in the present study (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) . However, it is argued on the basis of structural and bioinformatic analysis that physical interactions between CSD and CSDBM may be less common than believed since CSDBM is buried in many of the CSDBM containing proteins and thus inaccessible to bind CSD (45) . CSD sequence is embedded in the lipid bilayer (45, 46) that may also interfere CSD/CSDBM-dependent interactions (45, 46) . However, studies in which caveolae were reconstituted to determine binding of CSD and CSDBM containing proteins showed clear evidence of binding of some proteins, Src kinases (Src, Fyn) and dynamin-2 to non-phosphorylated Cav-1 and TRAF2 to Y-14 phosphorylated Cav-1 (47) . Our results based on multiple lines of evidence including using heterologous expression system and imaging showed that EphB1 binds the CSD of the non-phosphorylated Cav-1 via the EphB1 CSDBM.
The canonical Ephrin ligand/Eph receptor interaction mediates conformational changes in Eph receptor
which can activate Src tyrosine kinase (1, 2) . Phosphorylation of the conserved Y-600 in the cytoplasmic juxtamembrane region of EphB1 is essential for the recruitment and activation of Src (36) . Our 3D-SIM superresolution imaging and FRET studies showed that the ligand Ephrin B1 induced dissociation of EphB1 from Cav-1. We observed that the uncoupling unmasked the EphB1 kinase domain (which also contains CSDBM) to autophosphorylate EphB1 at Y-600 and induce Src kinase activation and subsequently Y-14 Cav-1 phosphorylation.
Co-expression of mutant EphB1 Y600F with WT-Cav-1 failed to induce phosphorylation of Src on Y416 and Cav-1 on Y-14. These findings thus show that EphB1/Cav-1 dissociation-mediated Src activation is a key switch responsible for phosphorylation of Y-14 Cav-1, the signal responsible for activating caveolae-mediated endocytosis (21) (22) (23) . While the basis of Src phosphorylation is not clear, a tenable mechanism may involve a conformation change induced by Ephrin B activation of EphB1 (1,2) that forces the uncoupling of EphB1 from Cav-1 and activation of Src kinase.
Cav-1 is essential for caveolae biogenesis in endothelial cells as evident most prominently by studies in which deletion of Cav-1 prevented the formation of caveolae (16, 19, 20) . CSD was key for caveolae biogenesis since caveolae did not form when CSD is deleted (46) . In the present study, we observed that deletion of CSDBM on EphB1 also disrupted the formation of caveolae. That both Cav-1 and EphB1 induced the same caveolae biogenesis defect suggests that Ephrin B1/Cav-1 interaction through CSD/CSDBM is a critical requirement for the formation of caveolae. An important question is why other proteins interacting with CSD of Cav-1 such as eNOS and Src do not influence the genesis of caveolae as was the case with Ephrin B1/Cav-1 interaction. Unlike EphB1, their loss did not disrupt caveolae biogenesis (48) . We showed that the transmembrane EphB1 is basally associated with Cav-1 at the plasma membrane unlike eNOS and Src (29, 32) .
The membrane association of Cav-1 and EphB1 may thus stabilize Cav-1 and facilitate the formation of homooligomers or hetero-oligomers with Cav-2 at the plasmalemma, which are important determinants for caveolae generation (13, 14, 49) .
We demonstrated that Src-dependent Cav-1 phosphorylation on Y-14 is essential for endocytosis via caveolae in ECs (21) (22) (23) . To address how EphB1 induced activation of Src in caveolae microdomains leads to phosphorylation of Cav-1, we determined Ephrin B1-induced Src activation and phosphorylation of Y-14 Cav-1 in ECs of EphB1 −/− mice. We observed that Ephrin B1-induced Src activation and Cav-1 phosphorylation were prevented in ECs of EphB1 −/− mice. Consistent with these results, caveolae-mediated endocytosis was also abrogated in ECs of EphB1 −/− mice. These findings thus indicate that EphB1 signaling plays a pivotal role in regulating Cav-1 function responsible for caveolae-mediated endocytosis in ECs.
The uptake of albumin in the endothelium via caveolae has remained a vexing question. Reports have suggested the existence of albumin binding proteins that promote binding and internalization of plasma albumin in caveolae and caveolar trafficking by a "pump" mechanism (50, 51) . The high ambient plasma albumin concentration of 3-4g% suggests that such a mechanism would be fully saturated and constitutively active, precluding any homeostatic control of interstitial oncotic pressure that is governed by the plasma albumin concentration; thus, the role of caveolae in trafficking macromolecular cargo such as albumin in the endothelium seems untenable (12, 45, 47) . We showed that the ligand of EphB1, Ephrin B1, itself induced Src phosphorylation on Y-14 Cav-1 and thereby activated the caveolar uptake and transport machinery. Our results thus suggest that EphB1 ligation by Ephrin B released into the plasma (1, 9, 52) 
Endothelial cells. Human lung microvascular endothelial cells (HLMVECs) and Endothelial growth media-2
(EGM-2) were purchased from Lonza (Walkersville, MD, USA). Lung endothelial cells (ECs) from mice were isolated with mAb to the adhesion molecule CD31 (PECAM-1) (53).
Immunoblotting. Endothelial cells were washed three times with phosphate-buffered saline (PBS) at 4°C and lysed in lysis buffer (50 mM Tris-HCl, pH7.5, 150 mM NaCl, 1 mM EGTA, 1% Triton X-100, 0.25% sodium deoxycholate, 0.1% SDS, 10 µM orthovanadate, and protease-inhibitor mixture) (54) . Mouse tissues were homogenized in lysis buffer (54) . EC lysates or tissue homogenates were resolved by SDS-PAGE on a 4-15% gradient separating gel under reducing conditions and transferred to a Duralose membrane. Membranes were blocked with 5% dry milk in TBST (10 mM Tris-HCl pH7.5, 150 mM NaCl, and 0.05% Tween-20) for 1 h RT and then incubated with the indicated primary antibody diluted in blocking buffer overnight at 4°C. For phosphospecific blots, membranes were incubated overnight at 4°C with the primary antibody diluted in TBST containing 5% bovine serum albumin. Next, membranes were washed three times and incubated with appropriate HRPconjugated secondary antibody. Protein bands were detected by enhanced chemiluminescence.
Immunostaining: Cells grown on High Tolerance Coverslips (pcs-170-1818, MatTek) were incubated with serum free medium (5 mM HEPES/HBSS, pH 7.4) for 2 h and stimulated with Ephrin B1-Fc (1 µg/ml) for indicated time periods. Cells were washed, fixed with 3% paraformaldehyde in HBSS, permeabilized with 0.1% Tween-20 in 5 mM HEPES/HBSS, pH 7.4, and blocked with 5% human serum diluted with 5 mM HEPES/HBSS, pH 7.4 (blocking buffer) for 2 h at room temperature. After blocking, cells were incubated with primary antibodies (1 µg/ ml), anti-EphB1 mouse mAb or anti-Cav-1 rabbit mAb in blocking buffer overnight at 4 o C.
Cells were washed and incubated with 1 µg/ml secondary antibody Alexa Fluor-647 goat anti-mouse and Alexa Fluor-488 chicken anti-rabbit for 1 h. After washing coverslips were mounted on a microscope slides with prolong gold-antifade reagent (Invitrogen).
Immunoprecipitation. Cell lysate (150 µg protein) was subjected to immunoprecipitation. Each sample was incubated overnight with 1 µg/ml of the indicated antibody at 4°C. The next day, protein A/G beads were added to the sample and incubated for 1 h at 4°C. Immunoprecipitates were then washed three times with wash buffer (Tris-buffered saline containing 0.05% Triton X-100, 1 mM Na3VO4, 1 mM NaF, 2 µg/ml leupeptin, 2 µg/ml pepstatin A, 2 µg/ml aprotinin, and 44 µg/ml phenylmethylsulfonyl fluoride). Immunoprecipitated proteins were used for immunoblotting.
3D-Structured Illumination Microscopy (SIM).
All 3D-SIM imaging was performed on a DeltaVision OMX SR system (GE) equipped with an Olympus 60X/1.42 NA objective and refractive index matched immersion oil (n=1.516-1.518) at room-temperature. Full-frame structure illuminated image sequences were taken at 125 nm Zaxis sections for multiple Z positions; the same exposure and excitation parameters were undertaken to avoid pixel saturation and maintain the validity of comparison across samples. 3D-SIM images were reconstructed using Softworx (Applied Precision) offline using a Wiener filter coefficient of 0.001. Reconstructed 3D-SIM data was further processed by Imaris software (Bitplane, Zurich, Switzerland). To ensure colocalization accuracy, all color channels in the 3D-SIM system have been aligned using standard samples. The image in each 3D dataset was processed using the Particle Analysis function in ImageJ to quantify the number and intensity of specific protein particles in each Z section. Caveolae endocytosis assay. Caveolae-mediated endocytosis of tracer albumin was measured as described (21, 22) . Briefly, endothelial cells grown on High Tolerance Coverslips (pcs-170-1818, MatTek) were washed, and incubated for 2 h in serum-free medium, followed Alexa Fluor 594-conjugated albumin (0.1 mg/ml Alexa Fluor 594-BSA mixed into 2 mg/ml of non-fluorescent BSA) in 5 mM HEPES-buffered HBSS at 37 0 C for 30 min (21, 22) . After this period of incubation, cells were washed, 3% paraformaldehyde in HBSS, permeabilized with 0.1% Tween-20 in 5 mM HEPES/HBSS, pH 7.4, and blocked with 5% human serum diluted with 5 mM HEPES/HBSS, pH 7.4 for 2 h at RT. After blocking, cells were incubated with anti-Cav-1 rabbit mAb (1 µg/ml) in blocking buffer overnight at 4 o C. Cells were washed and incubated with 1 µg/ml secondary antibody Alexa Fluor-488 chicken anti-rabbit for 1 h. After washing coverslips were mounted on a microscope slides with prolong gold-antifade reagent (Invitrogen).
Transmission Electron Microscopy (TEM). WT and EphB1
Endothelial permeability assay.
We determined transendothelial permeability in lung vessels in WT or EphB1 −/− mice were anesthetized using 2.5% sevoflurane in room air, and 2 µCi of 125 I-labeled albumin tracer injected intravenously according to an approved animal protocol. At 30 min after tracer injection, 100 µl blood sample withdrawn from a vein to determine blood tracer counts. Organs were then cleared of circulating tracer by wholebody perfusion via the right heart using RPMI supplemented with 3% unlabeled albumin and lungs were excised and counted for γ-radioactivity. Transendothelial albumin permeability was calculated in ml/min/g dry tissue from blood and tissues counts, and values were normalized to tissue dry weight as described (44) . To study the effects of the anti-EphB1 pAb on transendothelial albumin permeability, we used the method as described by us (53, 56) . Murine lungs were perfused via the pulmonary artery with RPMI solution containing 3% unlabeled albumin (2 ml/min, 37 o C). All preparations underwent a 20-min equilibration perfusion, and then received control Ab or anti-EphB1 pAb via a side-arm of the pulmonary artery cannula to achieve a final perfusate concentration of 5 µg/ml each. The 125 I-albumin tracer was infused via a separate side-arm for a 30 min-period.
A perfusate sample was collected to determine blood tracer counts and the washed out for 6 min, a period sufficient to reduce effluent counts to background levels. Lungs were counted for gamma radioactivity, and transendothelial albumin permeability was quantified in units of ml/min/g dry lung.
Statistical analysis. Results were analyzed by an unpaired two-tailed Student's t-test. Differences in mean values were considered significant at a p value <0.05.
Table 1. Albumin tracer particles/EC determined by 3D-SIM super resolution microscopy.
Values are Mean ± S.E.; n = 5/cells/genotype **P < 0.001, EphB1 +/+ -ECs vs EphB1 -/--ECs; **P < 0.001, Cav-1 +/+ -ECs vs Cav-1 -/--ECs. 
Time (min) EphB1 +/+ EphB1 -/-Cav-1 +/+
